Most Read News

Gaja Alternative Asset Management IPO GMP fell to ₹17 on August 21, 2026, from ₹30 on August 18. The latest GMP indicates an estimated listing price of ₹177, or a 10.62% premium, while the IPO is subscribed 4.54 times.

Tempsens Instruments IPO GMP has climbed to ₹277, indicating an estimated listing price of ₹577 against the upper issue price of ₹300. The IPO is subscribed 21.69 times, with strong demand across investor categories.

Hy-Tech Engineers IPO GMP stands at ₹22 on August 21, 2026, indicating an estimated listing price of ₹75 and a potential 41.51% premium over the upper issue price of ₹53.

Skyways Air IPO GMP stood at ₹45 on August 21, 2026, indicating an estimated listing price of ₹183 and a potential 32.61% premium over the upper IPO price of ₹138. Check the latest GMP trend, IPO details, financials and key dates.

IndiGo plans to increase international capacity to around 40% of its total capacity by FY30, with Airbus A350 aircraft, AI adoption and MRO investments supporting its long-term global expansion strategy.

Sugar stocks surged up to 18% on August 20 after the government tightened inventory limits for bulk sugar consumers. Here’s why Balrampur Chini, Dwarikesh Sugar and other sugar stocks are rallying.

Augmonth Enterprises IPO GMP holds at ₹300 on August 21, 2026, indicating an estimated listing price of ₹1,088 and a potential 38.07% premium. The IPO is subscribed 1.19 times overall.

BSE shares fell 3.24% from the intraday high after reports that NSE may allow its shares to trade on NSE following its proposed IPO. Here's what it means for BSE investors.

Symbiotec Pharmalab IPO GMP rises to ₹320 on August 21, 2026. At the upper IPO price of ₹988, the GMP indicates an estimated listing price of ₹1,308, or a potential 32.39% premium. Check IPO details, financials and valuation.

MCX shares surged over 5% on August 20 amid rising gold and silver prices, regulatory tailwinds and a technical breakout. Here's what is driving the MCX stock rally and the key levels to watch.